Stephen D. Simpson

Stephen D. Simpson

XMFWildWeasel

I'm an ex-Wall Street sell-side and buy-side analyst who has spent most of the last 10 years writing on a wide range of industries and investment ideas.

Recent articles



3M Delivers Again, but Mind the Multiple

Good organic growth and margin expansion support 3M as a leader in the industrial space, but valuations are getting steep.




Keep Calm and Carry On, Roche Stock

Roche continues to build upon the strongest oncology franchise in Big Pharma but could still use some non-oncology hits




Is Alkermes plc Stock Undervalued?

Strong science and underserved markets can fuel further gains from this delivery-focused biopharma




AbbVie Inc. Wins the Shire

AbbVie comes to terms for a deal that will significant reduce its tax bill and add some valuable diversification